ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/6/6/article-p536.xmlCancer- and Chemotherapy-Induced Anemia2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/6/6/article-p528.xmlReport on the NCCN Third Annual Patient Safety Summit2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/6/6/article-p528.pdf2026-04-18Report on the NCCN Third Annual Patient Safety Summithttps://harbor.dev.pubfactory.com/view/journals/jnccn/6/6/article-p523.xmlCenters of Excellence: What Should They Be?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/6/6/article-p523.pdf2026-04-18Centers of Excellence: What Should They Be?https://harbor.dev.pubfactory.com/view/journals/jnccn/6/6/article-p565.xmlErythropoiesis-Stimulating Agents in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/6/6/article-p565.pdf2026-04-18Erythropoiesis-Stimulating Agents in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/6/6/article-p577.xmlEstablishing an Anemia Clinic for Optimal Erythropoietic-Stimulating Agent Use in Hematology-Oncology Patients2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/6/6/article-p577.pdf2026-04-18Establishing an Anemia Clinic for Optimal Erythropoietic-Stimulating Agent Use in Hematology-Oncology Patientshttps://harbor.dev.pubfactory.com/view/journals/jnccn/6/6/article-p585.xmlIntravenous Iron in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/6/6/article-p585.pdf2026-04-18Intravenous Iron in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/6/6/article-p594.xmlHodgkin Disease/Lymphoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/6/6/article-p623.xmlRole of PET/CT Scanning in Initial and Post-Treatment Assessment of Hodgkin Disease2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/6/6/article-p623.pdf2026-04-18Role of PET/CT Scanning in Initial and Post-Treatment Assessment of Hodgkin Disease